g g g
ICS FOR ADVANCED PRACTICE-
g g g
A PRACTICAL APPROACH 5TH EDITION A
g g g g g g
RCANGELO FULLTESTBANKLATELYUPD
g
ATED2025 WITH VERIFIED SOLUTIONS|| G
g g g g
UARANTEED PASS!!! g
,1|Page
TESTgBANKgFORgPHARMACOTHERAPEUTICSgFORgADVANCEDgPRACTI
CE-
APRACTICALAPPROACH5THEDITIONARCANGELOFULLgTESTBANKgL
ATELYgUPDATEDg2025gWITHgVERIFIEDgSOLUTIONS||gGUARANTEEDgPA
SS!!!
Chapter01:IssuesforthePractitionerinDrugTherapyMULTIPLEgCH
OICE
1. Nursepractitionerprescriptiveauthorityisregulatedby:
A. TheNationalCouncilofStateBoardsofNursing
B. TheU.S.DrugEnforcementAdministration
C. TheStateBoardofNursingforeachstate
D. TheStateBoardofPharmacy
ANSWER_C POINTS:1
2. PhysicianAssistant(PA)prescriptiveauthorityisregulatedby:
A. TheNationalCouncilofStateBoardsofNursing
B. TheU.S.DrugEnforcementAdministration
C. TheStateBoardofNursing
D. TheStateBoardofMedicalExaminers
ANSWER_D POINTS:1
3. Clinicaljudgmentinprescribingincludes:
A. Factoringinthecosttothepatientofthemedicationprescribed
B. Alwaysprescribingthenewestmedicationavailableforthediseaseprocess
C. Handingoutdrugsamplestopoorpatients
D. Prescribingallgenericmedicationstocutcosts
,2|Page
ANSWER_A POINTS:1
4. Criteriagforchoosinganeffectivedrugforagdisorderinclude:
A. Askingthepatientwhatdrugtheythinkwouldworkbestgforthem
B. Consultingnationallyrecognizedguidelinesfordiseasemanagement
C. Prescribingmedicationsthatareavailableassamplesbeforewritingagpres
cription
D. FollowingU.S.DrugEnforcementAdministration(DEA)guidelinesforgpre
scribing
ANSWER_B POINTS:1
5. Nursepractitionerpracticemaythriveunderhealth-carereformdueto:
A. Thedemonstratedabilityofnursepractitionerstocontrolcostsandimprove gpatie
ntgoutcomes
B. Thefactthatnursepractitionerswillbeabletopracticeindependently
C. Thefactthatnursepractitionerswillhavefullreimbursementunderhealth-
gcaregreform
D. TheabilitytoshiftaccountabilityforMedicaidtothestatelevel
ANSWER_A POINTS:1
Chapter02:PharmacokineticBasisofTherapeuticsandPharmacodynamicgMULTIPL
EgCHOICE
1. Apatient'snutritionalintakeandlabworkreflectshypoalbuminemia.Thisis gcritic
algtogprescribinggbecause:
A. Distributionofdrugstotargettissuemaybeaffected
B. Thesolubilityofthedrugwillnotmatchthesiteofabsorption
, 3|Page
C. Therewillbeglessfreedrugavailabletogenerateaneffect
D. Drugsboundtoalbuminarereadilyexcretedbythekidney
ANSWER_A POINTS:1
2. Drugsthathaveasignificantfirst-passeffect:
A. Mustbegivenbytheenteral(oral)routeonly
B. Bypassthehepaticcirculation
C. Arerapidlymetabolizedbytheliverandmayhaveglittlegifanydesiredaction
D. Areconvertedbythelivertomoreactiveandfat-solubleforms
ANSWER_C POINTS:1
3. Therouteofexcretionofavolatiledrugwilllikelybe:
A. Thekidneys
B. Thelungs
C. Thebileandgfeces
D. Theskin
ANSWER_B POINTS:1
4. Medroxyprogesterone(DepoProvera)isprescribedIMtocreateastoragegrese
rvoirgofgthegdrug.gStoragegreservoirs:
A. Assurethatthedrugwillreachitsintendedtargettissue
B. Arethereasonforgivingloadingdoses
C. Increasetheglengthoftimeadrugisavailableandactive
D. Aremostcommonincollagentissues
ANSWER_C POINTS:1